Indianamed spa & injectable regulations
What’s changing for med spas and injectors in Indiana — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in Indiana. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.
Latest Indiana changes
- CRITICALLegiScan2026-03-05
IN SB0282: Compounding drugs; registration of medical spas.
New regulations for Indiana med spas take effect in 2027.
- CAUTIONLegiScan2026-03-04
IN HB1358: Indiana department of health.
Bill focuses on public health rather than aesthetic practices.
Federal changes that apply in Indiana
FDA and Federal Register actions are nationwide — they govern Indiana practices too.
- CRITICALFEDERALFDA Enforcement2025-09-10
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
FDA recalls compounded GLP-1 product for being subpotent.
- CRITICALFEDERALFDA Enforcement2025-08-13
FDA recall (Class II): Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
FDA recalls compounded GLP-1 product; check your stock now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
FDA recalls Wegovy; med spas must check supplies!
- CRITICALFEDERALFDA Enforcement2026-03-11
FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061,…
FDA recalls Semaglutide for sterility issues—act now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
FDA recalls Wegovy due to safety concerns; med spas must act.
- CRITICALFEDERALFDA Enforcement2025-07-02
FDA recall (Class II): Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80…
FDA recalls GLP-1 product over sterility issues.
What we monitor in Indiana
- Indiana legislature — bills on injectables, GLP-1s & scope of practice
- Indiana Board of Nursing — injector scope & delegation
- Indiana Medical Board — physician supervision & ownership rules
- Indiana Board of Pharmacy — compounding & 503A/503B
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
Indiana med spa compliance — FAQ
- Where do Indiana med spa and injectable regulations come from?
- Indiana med spas and injectors are governed by a mix of state and federal authorities — the Indiana legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for Indiana and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in Indiana?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in Indiana. We track those federal changes alongside any Indiana-specific rules so you see the full picture for your practice.
- How do I keep up with Indiana regulatory changes?
- Med Spa Radar sends a free weekly Brief on what changed across Indiana, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.
Never miss a Indiana change
Get the free weekly Brief on what changed across Indiana, the FDA, and the Federal Register. Members get the exact what-to-do, in real time, for their states.
Get the free Brief →← All states · Regulatory monitoring, not legal advice.